Editorial
Drug allergy labeling and delabeling in the coronavirus disease 2019 era: What is important and what do we need to know

https://doi.org/10.1016/j.anai.2020.04.012Get rights and content

Cited by (0)

Disclosures: The author has no conflicts of interest to report.

Funding: The author has no funding sources to report.

View Abstract
Published by Elsevier Inc. on behalf of the American College of Allergy, Asthma & Immunology.